Investors Tire of A...
Health Care: Drugs
DUSA Pharmaceuticals Inc. (DUSA: NASDAQ)
$4.73 -0.11 | -2.27%
02/10/12 - 11:17 AM ET
53.47K / 131.30K
Vol / Avg. Vol:4.82 / 4.84
Open / Prev. Close:4.62 - 4.82
Today's Range:2.81 - 6.83
52 Wk Range:10.50%
Performance YTD:TheStreet Rating:
Portfolios with DUSA
- Portfolio NameUser Type
- ContributorTop-Rated Biotechnology Stocks
- UserThatBobGuy Portfolio 1
- ContributorBarron's Insider Purchases ...
- ContributorTop 10 Insider Purchases: J...
- Userjoshuparks Portfolio 1
- Uservladys buttom fishing
- Userbill 3
- UserHeld's
Latest DUSA Headlines from TheStreet
- DUSA Pharmaceuticals Inc. Stock Upgraded (DUSA) 11.14.11 | 06:11 am
- DUSA Pharmaceuticals Inc. Stock Downgraded (DUSA) 07.28.11 | 07:07 am
- DUSA Stock Hits New 52-Week High (DUSA) 05.25.11 | 10:05 am
- DUSA Stock Soars (DUSA) 05.05.11 | 10:05 am
- DUSA Pharmaceuticals Inc. Stock Upgraded (DUSA) 03.04.11 | 05:03 pm
- DUSA Stock Soars Higher (DUSA) 03.03.11 | 10:03 am
- Cautious Bull
03.08.10 | 11:03 am - The Pisani Paradox 09.28.09 | 11:09 am
- Wednesday's Health Winners & Losers 10.03.07 | 03:10 pm
- Thursday's Small-Cap Winners & Losers 08.06.07 | 11:08 pm
Press Releases for DUSA
- DUSA Pharmaceuticals, Inc.® To Host First Quarter 2011 Corporate Highlights And Financial Results Webcast And Conference Call - Business Wire 04.28.11 | 08:04 am
- A Patient Receiving Levulan Photodynamic Therapy. (Photo: Business Wire) - Business Wire 03.03.11 | 06:03 am
- DUSA Pharmaceuticals, Inc.® To Host Fourth Quarter And Full Year 2010 Corporate Highlights And Financial Results Conference Call - Business Wire 02.25.11 | 06:02 am
- DUSA Pharmaceuticals To Present At The 4th Annual Maxim Group Growth Conference - PR Newswire 11.11.10 | 08:11 am
- DUSA Pharmaceuticals Named To Deloitte's 2010 Technology Fast 500 List Of Fastest Growing Companies In North America - PR Newswire 10.26.10 | 03:10 pm
- DUSA Pharmaceuticals To Present At The Rodman & Renshaw 12th Annual Healthcare Conference - PR Newswire 09.07.10 | 08:09 am
- DUSA Pharmaceuticals Receives Response From FDA On Orphan Drug Designation Status - PR Newswire 08.06.10 | 12:08 pm
- DUSA Pharmaceuticals Reports U.S. Patent Office Upholds Key Photodynamic Therapy Patent - PR Newswire 06.24.10 | 06:06 am
- DUSA Pharmaceuticals Announces Slate Of Nominees For Election To The Board Of Directors - PR Newswire 05.13.10 | 12:05 pm
- DUSA Pharmaceuticals Reports Notice Of Allowance For Key PDT Device Patent - PR Newswire 05.07.10 | 06:05 am
Partner Headlines for DUSA
- DUSA Pharmaceuticals Is A Small Gem - Seeking Alpha 12.23.11 | 02:12 pm
- 20 Smart Money Stock Picks Trading Under $5 - Seeking Alpha 11.03.11 | 07:11 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 07.01.11 | 09:07 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 03.07.11 | 09:03 am
- Morning Market Movers (GTEC, ASGR, LSBK, DUSA) - Benzinga 03.03.11 | 09:03 am
- UPDATE 1-DUSA to end skin drug deal with Stiefel Laboratories - Reuters 10.06.10 | 08:10 am
- UPDATE 1-DUSA to stop cancer trial as FDA denies orphan status - Reuters 08.06.10 | 02:08 pm
